![Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-021-00592-1/MediaObjects/41577_2021_592_Fig1_HTML.png)
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology
![Frontiers | Hesitation and Refusal Factors in Individuals' Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination Frontiers | Hesitation and Refusal Factors in Individuals' Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination](https://www.frontiersin.org/files/MyHome%20Article%20Library/626852/626852_Thumb_400.jpg)
Frontiers | Hesitation and Refusal Factors in Individuals' Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination
![Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27410-5/MediaObjects/41467_2021_27410_Fig1_HTML.png)
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
![IJERPH | Free Full-Text | Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic IJERPH | Free Full-Text | Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic](https://pub.mdpi-res.com/ijerph/ijerph-19-04930/article_deploy/html/images/ijerph-19-04930-ag.png?1650439764)
IJERPH | Free Full-Text | Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic
![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x675.jpg)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
![Natalie E. Dean, PhD on X: "2) Vaccine efficacy (VE) measures the relative reduction in infection/disease for the vaccinated arm versus the unvaccinated arm. A perfect vaccine would eliminate risk entirely, so Natalie E. Dean, PhD on X: "2) Vaccine efficacy (VE) measures the relative reduction in infection/disease for the vaccinated arm versus the unvaccinated arm. A perfect vaccine would eliminate risk entirely, so](https://pbs.twimg.com/media/EjAlZwaXcAEcmJx.png)
Natalie E. Dean, PhD on X: "2) Vaccine efficacy (VE) measures the relative reduction in infection/disease for the vaccinated arm versus the unvaccinated arm. A perfect vaccine would eliminate risk entirely, so
![Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance | Nature Medicine Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01877-1/MediaObjects/41591_2022_1877_Fig1_HTML.png)
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance | Nature Medicine
![Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK - ScienceDirect Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X18313203-gr1.jpg)
Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK - ScienceDirect
![Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01548-7/MediaObjects/41591_2021_1548_Fig1_HTML.png)